Project Grant D71TW009079

Federal Grant Award Summary Emory University received a $730,539 Project Grant award dated September 15, 2025, from the John E. Fogarty International Center under the International Research and Research Training program (CFDA 93.989) to build an India-Africa network for urban malaria research and control. The project addresses the unprecedented threat posed by the invasive Anopheles stephensi mosquito vector spreading across Africa, which poses direct risks to U.S. health security and military...

Federal Grant Award Summary The Infectious Diseases Institute LIMITED (IDI) in Uganda received a $302,160 Project Grant award from the Fogarty International Center under the International Research and Research Training program (CFDA 93.989), effective July 1, 2025 through February 29, 2028. The High-Performance Computing for HIV Research Excellence (HPC4HIV) initiative seeks to strengthen Uganda's capacity to conduct advanced biomedical and HIV research by addressing the growing computational...

Federal Grant Award Summary Duke University's Office of Research Administration received a $148,614 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective March 23, 2026, with a completion date of December 31, 2028. This fellowship award supports interdisciplinary research training and mentored experience in vector-borne disease epidemiology, migration health, and environmental...

Federal Project Grant Award Summary Brigham & Women's Hospital Inc. received a $170,411 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 8, 2025, with a completion date of July 31, 2030. This grant supports a mentorship and training initiative designed to develop the next generation of patient-oriented translational virologists and physician scientists. The...

Federal Grant Award Summary The Fogarty International Center (FIC) awarded $169,015 on September 16, 2025, under the International Research and Research Training program (CFDA 93.989) to Kenyatta National Hospital in Kenya to support the development and evaluation of a urine dipstick-guided counseling intervention designed to improve adherence and completion rates of the three-month isoniazid with rifapentine (3HP) tuberculosis preventive therapy (TPT) regimen among people with HIV. This...

Federal Grant Award Summary Duke University received a $362,312 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to establish TRIDENT (Transdisciplinary Research in Infectious Diseases to Engage Third-Year Medical Students). The award, effective September 1, 2025, through August 31, 2030, provides support for a structured mentorship and research training initiative targeting third-year...

Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $209,757 Project Grant to The Trustees of Columbia University in the City of New York (Health Sciences Division) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, effective September 15, 2025, with completion targeted for August 31, 2030, supports a mentorship-driven research initiative focused on multidrug-resistant tuberculosis (MDR-TB) adherence and...

Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Johns Hopkins University a $486,470 Project Grant effective August 11, 2025, through July 31, 2027, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports development and validation of direct-from-sample whole genome sequencing (WGS) methods for Neisseria gonorrhoeae that eliminate the need for isolate culturing, thereby reducing technical...

Federal Grant Award Summary George Washington University (GWU) received a $376,266 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 1, 2026 through April 30, 2031. The award funds the Building Research and Implementation Capacity for Driving Growth and Equity (BRIDGE) Training Collaborative Program, which provides research training and community-based experiential...

Federal Grant Award Summary Dalhousie University received a $283,694 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 16, 2025, through August 31, 2027. The award supports investigator-initiated research investigating Treponema pallidum pathobiology in the cervicovaginal niche to address the alarming global increase in infectious and congenital syphilis cases,...